Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioatla Inc (NQ: BCAB )

3.660 +0.090 (+2.52%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 413,481
Open 3.610
Bid (Size) 3.490 (1)
Ask (Size) 3.920 (1)
Prev. Close 3.570
Today's Range 3.540 - 3.770
52wk Range 2.235 - 12.15
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioAtla to Participate in the Jefferies Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
Where BioAtla Stands With Analysts
 
Via Benzinga

Performance

YTD
-54.70%
-54.70%
1 Month
+12.27%
+12.27%
3 Month
+17.31%
+17.31%
6 Month
-65.21%
-65.21%
1 Year
+36.57%
+36.57%

More News

Read More
BioAtla Reports First Quarter 2023 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in the JMP Securities Life Sciences Conference
From BioAtla, Inc.
Via GlobeNewswire
Expert Ratings for BioAtla
Via Benzinga
Earnings Outlook For BioAtla
Via Benzinga
BioAtla to Announce First Quarter 2023 Financial Results and Provide Business Highlights on May 11, 2023
From BioAtla, Inc.
Via GlobeNewswire
Around $1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
BioAtla Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Announce Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Highlights
From BioAtla, Inc.
Via GlobeNewswire
Earnings Scheduled For March 23, 2023
Via Benzinga
BioAtla Announces Change in Executive Leadership
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinoma
From BioAtla, Inc.
Via GlobeNewswire
Dow Rises Over 100 Points; Rayonier Advanced Materials Shares Plunge
Via Benzinga
Crude Oil Rises Over 1%; Oak Street Health Shares Spike Higher
Via Benzinga
US Stocks Open Higher; Nasdaq Rises 50 Points
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
BioAtla Provides Clinical Program Updates and Upcoming 2023 Milestones
From BioAtla, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
BioAtla to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in the Jefferies London Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
Dow Surges 150 Points; US Economy Adds 261,000 Jobs
Via Benzinga
BioAtla Announces $65 Million Underwritten Offering of its Common Stock
From BioAtla, Inc.
Via GlobeNewswire
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Via Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.